TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2024-03-26
謝思民Hsieh, Szu-Min
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
doceason1967@gmail.com
發表文獻
39筆
1
Chen GJ, Lin SW, Tsai IL, Kuo CH, Wang JT, Hsieh SM. Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation. J Formos Med Assoc. 2020 Jun;119(6):1086-1092. doi: 10.1016/j.jfma.2019.10.005. Epub 2019 Oct 28. PMID: 31672434.
2
Cheng A, Hsieh SM, Pan SC, Li YH, Hsieh EF, Lee HC, Lin TW, Lai KL, Chen C, Shi-Chung Chang S, Chang SC. The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trial. J Microbiol Immunol Infect. 2019 Oct;52(5):685-692. doi: 10.1016/j.jmii.2019.03.009. Epub 2019 May 18. PMID: 31255574.
3
Hsieh SM, Liu WD, Huang YS, Lin YJ, Hsieh EF, Lian WC, Chen C, Janssen R, Shih SR, Huang CG, Tai IC, Chang SC. Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study. EClinicalMedicine. 2021 Aug;38:100989. doi: 10.1016/j.eclinm.2021.100989. Epub 2021 Jun 26. PMID: 34222848; PMCID: PMC8233066.
4
Hsieh SM, Pan SC, Huang YS, Chang SC. Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study. J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):500-508. doi: 10.1097/QAI.0000000000002577. PMID: 33620177.
5
Hsu WT, Pan SC, Hsieh SM. 10-year outcome of temporary structured treatment interruption (STI) among HIV-1-infected patients: An observational study in a single medical center. J Formos Med Assoc. 2020 Jan;119(1 Pt 3):455-461. doi: 10.1016/j.jfma.2019.07.029. Epub 2019 Aug 10. PMID: 31409497.
6
Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019. J Formos Med Assoc. 2021 Nov;120(11):1994-2002. doi: 10.1016/j.jfma.2021.04.014. Epub 2021 May 5. PMID: 33962811.
7
Huang CF, Hsieh SM, Pan SC, Huang YS, Chang SC. Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2. Microorganisms. 2021 Jun 15;9(6):1303. doi: 10.3390/microorganisms9061303. PMID: 34203929; PMCID: PMC8232787.
8
Lee WS, Jean SS, Chen FL, Hsieh SM, Hsueh PR. Lemierre's syndrome: A forgotten and re-emerging infection. J Microbiol Immunol Infect. 2020 Aug;53(4):513-517. doi: 10.1016/j.jmii.2020.03.027. Epub 2020 Apr 4. PMID: 32303484.
9
Lee YC, Chiou CC, Wang JT, Yang YC, Tung SH, Hsieh SM. Non-traumatic perforation of the jejunum in a human immunodeficiency virus-infected patient receiving combination antiretroviral therapy: A case report. Medicine (Baltimore). 2019 Dec;98(49):e18163. doi: 10.1097/MD.0000000000018163. PMID: 31804330; PMCID: PMC6919416.
10
Lin KY, Sun HY, Chen YH, Lo YC, Hsieh SM, Sheng WH, Chuang YC, Pan SC, Cheng A, Hung CC, Fang CT, Chang SC. Effect of a Hepatitis A Vaccination Campaign During a Hepatitis A Outbreak in Taiwan, 2015-2017: A Modeling Study. Clin Infect Dis. 2020 Apr 10;70(8):1742-1749. doi: 10.1093/cid/ciz471. PMID: 31157857.
